HemaSphere (Jun 2022)
P1105: FINAL RESULTS OF THE PHASE I/II HOVON124/ECWM-R2 STUDY INCLUDING 2-YEAR RITUXIMAB MAINTENANCE AFTER INDUCTION WITH IXAZOMIB, RITUXIMAB AND DEXAMETHASONE IN RELAPSED WALDENSTRÖM’S MACROGLOBULINEMIA
- M.-A. Dimopoulos,
- K. Amaador,
- M. C. Minnema,
- K. Nasserinejad,
- M. Kap,
- E. Kastritis,
- M. Gavriatopoulou,
- W. Kraan,
- M. E. D. Chamuleau,
- D. Deeren,
- L. Tick,
- J. K. Doorduijn,
- F. Offner,
- L. H. Böhmer,
- R. D. Liu,
- S. T. Pals,
- J. M. Vos,
- M. J. Kersten
Affiliations
- M.-A. Dimopoulos
- 1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
- K. Amaador
- 2 Department Of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam
- M. C. Minnema
- 4 Department of Hematology, University Medical Center Utrecht, University Utrecht, Utrecht
- K. Nasserinejad
- 5 HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam
- M. Kap
- 5 HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam
- E. Kastritis
- 1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
- M. Gavriatopoulou
- 1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
- W. Kraan
- 3 LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam
- M. E. D. Chamuleau
- 7 Department of Hematology, Amsterdam UMC, VU University, Amsterdam, Netherlands
- D. Deeren
- 8 Department of Hematology, AZ Delta, Roeselare, Belgium
- L. Tick
- 9 Department of Hematology, Maxima Medical Center, Eindhoven
- J. K. Doorduijn
- 10 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
- F. Offner
- 11 Department of Hematology, University Hospital Gent, Gent, Belgium
- L. H. Böhmer
- 12 Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
- R. D. Liu
- 2 Department Of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam
- S. T. Pals
- 3 LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam
- J. M. Vos
- 2 Department Of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam
- M. J. Kersten
- 2 Department Of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam
- DOI
- https://doi.org/10.1097/01.HS9.0000847288.62394.e8
- Journal volume & issue
-
Vol. 6
pp. 995 – 996
Abstract
No abstracts available.